Senti Biosciences Holdings SNTI Income Statement (2021-2026)

NASDAQ SNTI
$0.16 +0.02 (+11.81%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Senti Biosciences Holdings Quarterly Income Statement

Periods 22 quarters
Latest Jun 2026

Senti Biosciences Holdings reported revenue of $0.02M and net income of -$12.75M for the quarter ended Jun 2026. This income statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
1.10M0.79M1.10M1.36M1.77M0.06M1.29M0.94M0.34M0.17M0.10M0.02M0.02M
Operating items
Research & DevelopmentR&D
5.41M6.41M7.60M9.25M6.52M7.04M7.06M6.88M9.09M9.12M8.78M9.15M8.66M7.77M9.28M10.03M10.52M7.76M5.28M7.77M
Selling, General & AdministrativeSG&A
7.12M5.27M5.26M13.88M10.00M9.82M9.19M9.25M9.43M9.31M7.52M4.21M6.56M8.08M7.12M6.77M6.43M5.85M6.23M6.74M
Other Operating ExpensesOther Opex
-8.88M0.10M-0.72M-0.06M-0.15M-0.02M5.05M-6.88M
Operating ExpensesOpex
12.53M11.68M12.86M23.13M16.51M16.85M16.25M16.13M44.21M18.70M16.30M13.36M15.22M16.17M16.40M16.80M16.95M18.66M4.63M14.51M
Operating IncomeOp. Inc
-11.42M-10.89M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.22M-16.17M-16.40M-16.80M-16.95M-18.64M-4.62M-14.49M
Non-operating items
Goodwill impairment chargesGoodwill Impair.
25.69M0.27M0.31M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
0.00M0.00M0.00M
Interest & Investment IncomeInt & Inv Inc
0.00M0.02M
Other Non Operating IncomeOther Non Op Inc.
0.02M-0.01M-0.05M1.31M0.00M0.00M-0.01M0.00M-0.01M-0.01M0.01M-0.01M0.21M0.20M0.21M0.22M0.19M0.20M0.84M
Non Operating IncomeNon Op. Inc.
0.02M-0.02M-0.05M10.22M0.45M1.81M1.11M0.94M7.26M0.01M4.19M2.15M-13.65M15.56M2.29M2.07M-1.18M4.17M0.40M1.74M
Net income details
EBIT
-11.42M-10.89M-11.76M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.22M-16.17M-16.40M-16.80M-16.95M-18.64M-4.62M-14.49M
EBT
-11.42M-10.89M-11.73M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.22M-16.17M-16.40M-16.80M-16.95M-18.64M-4.62M-14.49M
Income After Tax
-11.42M-10.89M-11.73M-21.77M-14.75M-16.79M-14.96M-15.19M-43.88M-18.70M-16.30M-13.36M-15.22M-16.17M-16.40M-16.80M-16.95M-18.64M-4.62M-14.49M
Income from Continuing OperationsIncome (Continuing)
-11.42M-10.89M-11.73M-21.77M-14.30M-49.67M-13.85M-14.25M-36.62M-83.41M-12.11M-11.20M-28.87M-0.61M-16.40M-16.80M-16.95M-18.64M-4.62M-14.49M
Income from Discontinued OperationsIncome (Discontinued)
-2.34M-8.55M-4.87M-4.45M21.69M-0.03M
Consolidated Net IncomeConsol Net Inc.
-11.41M-10.90M-11.81M-11.55M-16.64M-18.21M-18.72M-18.70M-14.92M-18.72M-12.11M-11.20M-28.87M-0.61M-14.11M-14.73M-18.13M-14.47M-4.22M-12.75M
Income towards Parent CompanyParent Net Inc
-11.41M-10.90M-11.81M-11.55M-16.64M-58.21M-18.72M-18.70M-14.92M-71.06M-12.11M-11.20M-28.87M-0.60M-14.11M-14.73M-18.13M-14.44M-4.22M-12.75M
Net Income towards Common StockholdersNet Income
-11.41M-10.90M-11.81M-11.55M-16.64M-58.21M-18.72M-18.70M-14.92M-71.06M-12.11M-11.20M-28.87M-0.60M-14.11M-14.73M-18.13M-14.44M-4.22M-12.75M
Additional items
EPS (Basic)
-3.87-37.44-4.01-8.59-3.83-22.29-4.25-4.22-3.36-16.01-2.65-2.45-6.31-0.13-1.41-0.56-0.69-0.64-0.14-0.41
EPS (Diluted)
-38.98-37.44-37.23-8.59-3.83-22.29-4.25-4.22-3.36-16.01-2.65-2.45-6.31-0.13-1.41-0.56-0.69-0.64-0.14-0.41
Shares Outstanding
2.95M0.29M2.95M1.34M4.34M2.61M4.41M4.43M4.45M4.44M4.57M4.57M4.58M4.60M10.01M26.08M26.23M22.48M30.97M31.14M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.29M0.29M0.32M1.34M4.34M2.61M4.41M4.43M4.45M4.44M4.57M4.57M4.58M4.60M10.01M26.08M26.23M22.48M30.97M31.14M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.95M0.65M2.95M1.34M4.36M2.61M4.41M4.45M4.45M4.57M4.57M4.57M4.59M4.60M10.01M26.16M26.29M22.48M31.14M31.14M
EBITDA
-11.22M-10.63M-11.52M-21.47M-14.35M-16.34M-14.50M-14.39M-42.53M-17.71M-15.32M-12.39M-14.27M-15.23M-15.47M-15.88M-16.04M-17.74M-3.93M-13.82M

Senti Biosciences Holdings Income Statement API

Pull Senti Biosciences Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SNTI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY